Cargando…
Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease
Infants suffering from neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, are facing long-term consequences determined by individual genetic background, presence of infections, and postnatal treatment strategies such as mechanical ventilation and oxygen toxicity. The adverse effects pr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200413/ https://www.ncbi.nlm.nih.gov/pubmed/34136503 http://dx.doi.org/10.3389/fmed.2021.665152 |
_version_ | 1783707596825296896 |
---|---|
author | Sucre, Jennifer Haist, Lena Bolton, Charlotte E. Hilgendorff, Anne |
author_facet | Sucre, Jennifer Haist, Lena Bolton, Charlotte E. Hilgendorff, Anne |
author_sort | Sucre, Jennifer |
collection | PubMed |
description | Infants suffering from neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, are facing long-term consequences determined by individual genetic background, presence of infections, and postnatal treatment strategies such as mechanical ventilation and oxygen toxicity. The adverse effects provoked by these measures include inflammatory processes, oxidative stress, altered growth factor signaling, and remodeling of the extracellular matrix. Both, acute and long-term consequences are determined by the capacity of the immature lung to respond to the challenges outlined above. The subsequent impairment of lung growth translates into an altered trajectory of lung function later in life. Here, knowledge about second and third hit events provoked through environmental insults are of specific importance when advocating lifestyle recommendations to this patient population. A profound exchange between the different health care professionals involved is urgently needed and needs to consider disease origin while future monitoring and treatment strategies are developed. |
format | Online Article Text |
id | pubmed-8200413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82004132021-06-15 Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease Sucre, Jennifer Haist, Lena Bolton, Charlotte E. Hilgendorff, Anne Front Med (Lausanne) Medicine Infants suffering from neonatal chronic lung disease, i.e., bronchopulmonary dysplasia, are facing long-term consequences determined by individual genetic background, presence of infections, and postnatal treatment strategies such as mechanical ventilation and oxygen toxicity. The adverse effects provoked by these measures include inflammatory processes, oxidative stress, altered growth factor signaling, and remodeling of the extracellular matrix. Both, acute and long-term consequences are determined by the capacity of the immature lung to respond to the challenges outlined above. The subsequent impairment of lung growth translates into an altered trajectory of lung function later in life. Here, knowledge about second and third hit events provoked through environmental insults are of specific importance when advocating lifestyle recommendations to this patient population. A profound exchange between the different health care professionals involved is urgently needed and needs to consider disease origin while future monitoring and treatment strategies are developed. Frontiers Media S.A. 2021-05-31 /pmc/articles/PMC8200413/ /pubmed/34136503 http://dx.doi.org/10.3389/fmed.2021.665152 Text en Copyright © 2021 Sucre, Haist, Bolton and Hilgendorff. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Sucre, Jennifer Haist, Lena Bolton, Charlotte E. Hilgendorff, Anne Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease |
title | Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease |
title_full | Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease |
title_fullStr | Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease |
title_full_unstemmed | Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease |
title_short | Early Changes and Indicators Characterizing Lung Aging in Neonatal Chronic Lung Disease |
title_sort | early changes and indicators characterizing lung aging in neonatal chronic lung disease |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200413/ https://www.ncbi.nlm.nih.gov/pubmed/34136503 http://dx.doi.org/10.3389/fmed.2021.665152 |
work_keys_str_mv | AT sucrejennifer earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease AT haistlena earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease AT boltoncharlottee earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease AT hilgendorffanne earlychangesandindicatorscharacterizinglungaginginneonatalchroniclungdisease |